Metastatic Castration Sensitive Prostate Cancer (mCSPC) (DBCOND0154644)
Identifiers
- Synonyms
- Metastatic Castration Sensitive Prostate Cancer / Metastatic Castration-sensitive Prostate Cancer / Metastatic Castrate Sensitive Prostate Cancer / Metastatic Castrate-sensitive Prostate Cancer
Associated Data
- Indicated Drugs and Targets
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT05701007 Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland Not Available Not Available completed NCT02020070 Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy No drug interventions treatment 2 active_not_recruiting NCT04601441 Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan screening 4 recruiting NCT05149131 A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer No drug interventions Not Available Not Available completed NCT06120491 Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents treatment 3 recruiting NCT04887506 TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer No drug interventions treatment 3 completed NCT04666129 Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer No drug interventions treatment 1 active_not_recruiting NCT04497844 A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) No drug interventions treatment 3 active_not_recruiting NCT05884398 A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC treatment 3 recruiting